EdgarLookup

Enliven Therapeutics, Inc. — 10-Q Filings

18 10-Q filings on record

This page lists all 10-Q filings submitted to the SEC by Enliven Therapeutics, Inc. (ELVN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Enliven Therapeutics, Inc. has filed 18 10-Q documents with the SEC since 2016. To view all SEC filings by Enliven Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 144/A 3 4 4/A 424B3 424B4 424B5 425 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFM14A DRS DRS/A DRSLTR EFFECT PRE 14A PREM14A S-1 S-1/A S-3 S-3ASR S-3MEF S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
10-Q 10-Q 0001193125-25-277619 Nov 12, 2025 Sep 30, 2025
10-Q 10-Q 0001193125-25-179845 Aug 13, 2025 Jun 30, 2025
10-Q 10-Q 0000950170-25-071412 May 14, 2025 Mar 31, 2025
10-Q 10-Q 0000950170-24-126332 Nov 13, 2024 Sep 30, 2024
10-Q 10-Q 0000950170-24-096239 Aug 13, 2024 Jun 30, 2024
10-Q 10-Q 0000950170-24-059573 May 14, 2024 Mar 31, 2024
10-Q 10-Q 0000950170-23-062080 Nov 9, 2023 Sep 30, 2023
10-Q 10-Q 0000950170-23-041349 Aug 10, 2023 Jun 30, 2023
10-Q 10-Q 0000950170-23-021262 May 11, 2023 Mar 31, 2023
10-Q 10-Q 0001564590-22-035098 Oct 25, 2022 Sep 30, 2022
10-Q 10-Q 0001564590-22-027795 Aug 3, 2022 Jun 30, 2022
10-Q 10-Q 0001564590-22-018458 May 6, 2022 Mar 31, 2022
10-Q 10-Q 0001564590-21-055446 Nov 9, 2021 Sep 30, 2021
10-Q 10-Q 0001564590-21-041904 Aug 6, 2021 Jun 30, 2021
10-Q 10-Q 0001564590-21-026283 May 11, 2021 Mar 31, 2021
10-Q 10-Q 0001564590-20-050867 Nov 5, 2020 Sep 30, 2020
10-Q 10-Q 0001564590-20-040173 Aug 14, 2020 Jun 30, 2020
10-Q 10-Q 0001564590-20-022393 May 7, 2020 Mar 31, 2020